Document:

Exhibit
10.15

 

ETHANOL
GRAIN PROCESSORS, LLC

A
Tennessee Limited Liability Company

1918
McDonald Road

Rives, Tennessee 38253

 

February 1, 2006

 

Ethanol Capital Management, LLC

Attn: Mr. Scott Brittenham

Rockefeller Center, 7th Floor

1230 Avenue of the Americans

New York, New York 10020

 

Re: Indication of
Interest

 

Dear Mr. Brittenham:

 

Thank you for the interest of Ethanol Capital
Management (“ECM”) in participating in the planned initial public offering (the
“Offering”) of capital units of Ethanol Grain Processors, LLC (the “Company”).

 

As you know, in contemplation of the
Offering, the Company has filed a registration statement on Form SB-2 (SEC file
no. 333-130815) with the SEC. The filing of the registration statement included
a preliminary prospectus dated December 30, 2005. This letter confirms the
delivery of a copy of the registration statement including the preliminary
prospectus to you, and your receipt thereof, on or about January 10th, 2006.

 

NOTICE: A
registration statement relating to these securities has been filed with the
Securities and Exchange Commission but has not yet become effective. These
securities may not be sold nor may offers to buy be accepted prior to the time
the registration statement becomes effective. This communication shall not
constitute an offer to sell or the solicitation of an offer to buy, nor shall
there be any sale of, these securities in any state in which such offer,
solicitation or sale would be unlawful prior to registration or qualification
under the securities laws of any such state. To obtain a prospectus, please
contact the company’s Chief Executive Officer, James K. Patterson, by calling
(731) 536-1286. Or by mail at P.O. Box 95, Obion, TN 38240.

 

Subject to the foregoing, we wish to inform
you that the Board of Governors of the Company has approved the following
changes to the Offering:

 

•                  removal of the
early subscription incentives and reduced pricing provided for in the original
registration statement filing, such that all units offered and sold in the Offering
will be at a price of $2.00 per unit; and

 

•                  reduction of the
Offering to a maximum of 31,175,000 units, or $62,350,000.

 

In addition, the Board of Governors has
approved a plan to issue additional units and options to existing unit holders
and option holders on a pro rata basis at an approximately 2.23535:1 ratio,
such that, upon financial closing, the existing unit holders and option holders
will hold 7,000,000 units on a fully diluted basis, with capital accounts equal
to $14,000,000 or $2.00 per unit. Those units do not include (a) the
anticipated issuance of units subscribed for in the Offering, (b) the
anticipated issuance of 1,250,000 units upon closing of the Company’s prior
private escrow offering, or (c) the anticipated issuance of 575,000 units upon
exercise of the Company’s site purchase option with Obion Grain Co. Therefore,
based upon the Company’s current capitalization as adjusted for all of the
anticipated issuances described in this paragraph and assuming the

 

maximum amount offered in the Offering is
sold, there will be a total of 40,000,000 units outstanding on a fully-diluted
basis at financial closing.

 

As a result of the issuances of units in the
Offering, the prior private escrow offering, and the exercise of the Company’s
site purchase option (assuming the maximum amount offered in the Offering is
sold, the issuances will total 33,000,000 units at $2.00 per unit for total
capital contributions of $66,000,000), the Board also approved a change in the
Offering to provide for a revaluation of the Company’s assets at financial
closing such that the aggregate capital accounts of all unit holders equal
$80,000,000 assuming 40,000,000 units outstanding, or $2.00 per unit, and to
further provide that 100% of the resulting book-up in capital accounts
($10,698,500) will be credited to the capital accounts of the units holders and
option holders immediately prior to financial closing.

 

The issuance of the additional units at
financial closing described herein is necessary to adjust the number of capital
units held by the existing unit holders and option holders such that the number
of capital units held or under option will be 7,000,000 units and will be in
proportion to the aggregate amount of their capital accounts of $14,000,000
following the revaluation.

 

The Board also approved a change to the
Offering to provide that any member who together with affiliates owns more than
50% of the total units outstanding will be entitled to appoint a simple
majority of the number of governors serving on the Company’s Board of
Governors, and that, with the number of governors established as 11 at
financial closing, such member will be entitled to fill and appoint governors
to 6 out of the 11 board seats on the Company’s Board of Governors.

 

Please countersign below to formally indicate
ECM’s interest in subscribing for 20,000,000 capital units, or $40,000,000, in
the Offering under the above terms. We acknowledge that this indication of
interest will be non-binding and that ECM will have no obligation to subscribe
for or purchase any capital units in the Offering. This indication of interest
will not be deemed an offer to purchase any capital units in the Offering.

 

We are preparing an amendment to the
registration statement to incorporate the above changes in the Offering and the
Company’s anticipated capitalization. We will also be preparing
amendments to our operating agreement to incorporate the revaluation and
anticipated capitalization. We hereby inform you that, assuming the registration statement, as amended, is
declared effective by the SEC and subject to applicable state securities laws,
if ECM and/or its affiliates subscribe to purchase 20,000,000 capital units in
the Offering after effectiveness, in accordance with the terms of the amended
registration statement and the final prospectus, the Company will accept the
subscription, subject to all terms and conditions thereof, including
fulfillment of all obligations under such subscription and the related
promissory note, provided that due diligence on ECM and its affiliates and
appropriate disclosure thereof under federal and state securities laws
indicates no past issues or legal proceedings that cause unfavorable disclosure
in connection with the purchase; and provided further that such subscription to
purchase must be received by the Company within 30 days of the date of
effectiveness or April 30, 2006, whichever occurs later.

 

Note that the terms of the preceding sentence
will be null and void unless we receive a countersigned copy of this letter before
5:00 p.m. (CST) on February 1, 2006.

 

 

Please feel free to contact me with any
further questions you may have regarding Ethanol Grain Processors or its
ethanol project. We look forward to sending you a final prospectus and
subscription materials when available.

 

ETHANOL GRAIN PROCESSORS, LLC

 

 

	
   

  	
  /s/ James K. Patterson

  	
   

  
	
  James K. Patterson

  	
   

  
	
  Chief Executive Officer

  	
   

  

 

 

INDICATION
OF INTEREST:

 

ECM hereby indicates its
interest in subscribing for 20,000,000 capital units, or $40,000,000, in the
Offering under the terms outlined in the foregoing letter. This indication of
interest will be non-binding and ECM will have no obligation to subscribe for
or purchase any capital units in the Offering. This indication of interest will
not be deemed an offer to purchase any capital units in the Offering.

 

ETHANOL CAPITAL MANAGEMENT, LLC

 

 

	
   

  	
  /s/ Scott Brittenham

  	
   

  	
   

  	
  2-1-06

  	
   

  
	
  Signature

  	
  Date

  
	
   

  	
   

  
	
   

  	
  Scott Brittenham

  	
   

  	
   

  
	
  Print Name

  	
   

  
	
   

  	
   

  
	
   

  	
  President & CEO

  	
   

  	
   

  
	
  TitleExhibit 10.1

 

EXECUTION
VERSION

 

PRIVILEGED
AND CONFIDENTIAL

PROVIDED
AS PART OF SETTLEMENT DISCUSSIONS

SUBJECT
TO RULE 408 OF THE FEDERAL RULES OF EVIDENCE

AND ALL
BANKRUPTCY AND STATE LAW EQUIVALENTS

 

THIRD
AMENDMENT TO PLAN SUPPORT AGREEMENT REGARDING

CURATIVE
HEALTH SERVICES, INC. AND ITS SUBSIDIARIES

 

THIS THIRD AMENDMENT TO PLAN SUPPORT
AGREEMENT (this “Amendment”), is entered into as of March 15,
2006, by and among (a) Curative Health Services, Inc., and its
subsidiaries(1) (collectively, the “Company” or “Curative”);
and (b) the holders (or investment managers or advisers for the beneficial
owners) identified on Schedule 1 (the “Supporting Noteholders”)
of the Curative Health Services, Inc. $185 million 103/4%
Senior Notes Due 2011 (the “Senior Notes”) who are Parties (or their
successors) to that Plan Support Agreement, dated as of December 2, 2005
(as amended, the “Agreement”). Capitalized terms used but not otherwise
defined herein shall have the meanings assigned to them in the Agreement.

 

WHEREAS, the Agreement was amended on December 14,
2005, and on February 3, 2006.

 

WHEREAS, the Agreement contains a provision stating
that all obligations under the Agreement shall automatically terminate if the
Company fails to file the Plan with the Bankruptcy Court by March 15,
2006.

 

WHEREAS, Curative and the Supporting Noteholders wish
to extend the date by which the Company must file the Plan as set forth herein.

 

NOW, THEREFORE, in consideration of the premises and
the mutual covenants and agreements set forth herein, and for other good and
valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, each of the Parties hereto hereby agrees as follows:

 

1.                                       Amendments. The Agreement is hereby
amended as follows:

 

(a) Section 7(iii) of
the Agreement is hereby amended by replacing the phrase “the Company fails to
file the Plan with the Bankruptcy Court by March 15, 2006” with the phrase
“the Company fails to file the Plan with the Bankruptcy Court by March 28,
2006.”

 

(1) The subsidiaries
which are parties to this Agreement are: 
Apex Therapeutic Care, Inc., eBioCare.com, Inc., CHS Services, Inc.,
Hemophilia Access, Inc., Infinity Infusion, LLC, Infinity Infusion II,
LLC, Infinity Infusion Care, Ltd., Curative Health Services of New York, Inc.,
Optimal Care Plus, Inc., MedCare, Inc., Critical Care Systems, Inc.,
Curative Health Services Co., Curative Health Services III Co., and Curative
Pharmacy Services, Inc.

 

 

2.                                       No Further Effect. Nothing in this Amendment
shall be deemed to amend, modify, supplement, waive, discharge or terminate or
otherwise alter the Agreement or any term or condition thereof or any Exhibit or
Schedule thereto, or any remedy available thereunder, in any manner other
than as expressly stated in Section 1 hereof.

 

3.                                       Counterparts; Fax Signatures. This Amendment may be
executed in two or more counterparts, each of which shall be deemed an
original, but all of which together shall constitute one and the same
instrument. Delivery of an executed counterpart of a signature page by
facsimile transmission shall be effective as delivery of a manually executed
counterpart.

 

4.                                       Governing Law. Except to the extent that the
Bankruptcy Code or Bankruptcy Rules are applicable, the rights and
obligations arising under this Amendment shall be governed by, and construed
and enforced in accordance with, the laws of the State of New York applicable
to contracts made and performed entirely within such state.

 

IN WITNESS WHEREOF, each of the Parties
hereto has caused this Amendment to be executed and delivered by its duly
authorized officers as of the date first written above.

 

[Remainder of page intentionally blank; signature
pages follow]

 

 

	
   

  	
  CURATIVE
  HEALTH SERVICES, INC.,

  
	
   

  	
  a
  Minnesota corporation formerly known as

  Curative Holding Co.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
   

  
	
   

  	
  Name:

  	
   

  	
   

  
	
   

  	
  Title:

  	
   

  	
   

  
	
   

  	
  Date:

  	
   

  	
   

  
						

 

 

	
   

  	
  EBIOCARE.COM, INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
   

  
	
   

  	
  Name:

  	
   

  	
   

  
	
   

  	
  Title:

  	
   

  	
   

  
	
   

  	
  Date:

  	
   

  	
   

  
						

 

 

	
   

  	
  HEMOPHILIA
  ACCESS, INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
   

  
	
   

  	
  Name:

  	
   

  	
   

  
	
   

  	
  Title:

  	
   

  	
   

  
	
   

  	
  Date:

  	
   

  	
   

  
						

 

 

	
   

  	
  APEX
  THERAPEUTIC CARE, INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
   

  
	
   

  	
  Name:

  	
   

  	
   

  
	
   

  	
  Title:

  	
   

  	
   

  
	
   

  	
  Date:

  	
   

  	
   

  
						

 

 

	
   

  	
  CHS
  SERVICES, INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
   

  
	
   

  	
  Name:

  	
   

  	
   

  
	
   

  	
  Title:

  	
   

  	
   

  
	
   

  	
  Date:

  	
   

  	
   

  
						

 

 

	
   

  	
  CURATIVE
  HEALTH SERVICES OF NEW

  YORK, INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
   

  
	
   

  	
  Name:

  	
   

  	
   

  
	
   

  	
  Title:

  	
   

  	
   

  
	
   

  	
  Date:

  	
   

  	
   

  
						

 

 

	
   

  	
  OPTIMAL
  CARE PLUS, INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
   

  
	
   

  	
  Name:

  	
   

  	
   

  
	
   

  	
  Title:

  	
   

  	
   

  
	
   

  	
  Date:

  	
   

  	
   

  
						

 

 

	
   

  	
  INFINITY
  INFUSION, LLC

  
	
   

  	
   

  
	
   

  	
  By:
  Curative Health Services Co., its Sole

  Member

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
   

  
	
   

  	
  Name:

  	
   

  	
   

  
	
   

  	
  Title:

  	
   

  	
   

  
	
   

  	
  Date:

  	
   

  	
   

  
						

 

 

	
   

  	
  INFINITY
  INFUSION II, LLC

  
	
   

  	
   

  
	
   

  	
  By:
  Curative Health Services Co., its Sole

  Member

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
   

  
	
   

  	
  Name:

  	
   

  	
   

  
	
   

  	
  Title:

  	
   

  	
   

  
	
   

  	
  Date:

  	
   

  	
   

  
						

 

 

	
   

  	
  INFINITY
  INFUSION CARE, LTD.

  
	
   

  	
   

  
	
   

  	
  By:
  Infinity Infusion II, LLC, its Sole General

  Partner

  
	
   

  	
   

  
	
   

  	
  By:
  Curative Health Services Co., the Sole

  Member of Infinity Infusion II, LLC

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
   

  
	
   

  	
  Name:

  	
   

  	
   

  
	
   

  	
  Title:

  	
   

  	
   

  
	
   

  	
  Date:

  	
   

  	
   

  
						

 

 

	
   

  	
  MEDCARE, INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
   

  
	
   

  	
  Name:

  	
   

  	
   

  
	
   

  	
  Title:

  	
   

  	
   

  
	
   

  	
  Date:

  	
   

  	
   

  
						

 

 

	
   

  	
  CURATIVE
  PHARMACY SERVICES, INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
   

  
	
   

  	
  Name:

  	
   

  	
   

  
	
   

  	
  Title:

  	
   

  	
   

  
	
   

  	
  Date:

  	
   

  	
   

  
						

 

 

	
   

  	
  CURATIVE
  HEALTH SERVICES CO.,

  
	
   

  	
  a
  Minnesota corporation formerly known as

  Curative Health Services, Inc.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
   

  
	
   

  	
  Name:

  	
   

  	
   

  
	
   

  	
  Title:

  	
   

  	
   

  
	
   

  	
  Date:

  	
   

  	
   

  
						

 

 

	
   

  	
  CRITICAL
  CARE SYSTEMS, INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
   

  
	
   

  	
  Name:

  	
   

  	
   

  
	
   

  	
  Title:

  	
   

  	
   

  
	
   

  	
  Date:

  	
   

  	
   

  
						

 

 

	
   

  	
  CURATIVE HEALTH SERVICES III CO.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
   

  
	
   

  	
  Name:

  	
   

  	
   

  
	
   

  	
  Title:

  	
   

  	
   

  
	
   

  	
  Date:

  	
   

  	
   

  
						

 

 

SCHEDULE 1

Supporting
Noteholders

 

1.          AIG Global Investment
Corp., as advisor and sub-advisor for certain funds and accounts.

 

2.          Barclays Bank PLC

 

3.          BlackRock Financial
Management, Inc., as Investment Advisor/Sub-Advisor to various accounts.

 

4.          Merrill Lynch, Pierce,
Fenner & Smith Incorporated (but only in its capacity as the holder of
Senior Notes for the account of the Merrill Lynch Principal Credit Group; this
Agreement shall not bind or otherwise apply to Merrill Lynch, Pierce, Fenner &
Smith Incorporated in any other capacity or with respect to any other Senior
Notes that may be held by it)

 

5.          RCG Carpathia Master
Fund, Ltd.

 

 

	
   

  	
  AIG
  Global Investment Corp. (as advisor and

  sub-advisor for certain funds and accounts)

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
   

  
	
   

  	
  Name:

  	
   

  	
   

  
	
   

  	
  Title:

  	
   

  	
   

  
	
   

  	
  Date:

  	
   

  	
   

  
						

 

 

	
   

  	
  Barclays Bank PLC

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
   

  
	
   

  	
  Name:

  	
   

  	
   

  
	
   

  	
  Title:

  	
   

  	
   

  
	
   

  	
  Date:

  	
   

  	
   

  
						

 

 

	
   

  	
  BlackRock Financial Management, Inc.
  (as

  Investment Advisor/Sub-Advisor to various

  accounts)

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
   

  
	
   

  	
  Name:

  	
   

  	
   

  
	
   

  	
  Title:

  	
   

  	
   

  
	
   

  	
  Date:

  	
   

  	
   

  
						

 

 

	
   

  	
  Merrill Lynch, Pierce, Fenner &
  Smith

  Incorporated (but only in its capacity as the

  holder of Senior Notes for the account of the

  Merrill Lynch Principal Credit Group; this

  Agreement shall not bind or otherwise apply to

  Merrill Lynch, Pierce, Fenner & Smith

  Incorporated in any other capacity or with

  respect to any other Senior Notes that may be

  held by it)

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
   

  	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
   

  
	
   

  	
  Name:

  	
   

  	
   

  
	
   

  	
  Title:

  	
   

  	
   

  
	
   

  	
  Date:

  	
   

  	
   

  
						

 

 

	
   

  	
  RCG Carpathia Master Fund, Ltd.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
   

  
	
   

  	
  Name:

  	
   

  	
   

  
	
   

  	
  Title:

  	
   

  	
   

  
	
   

  	
  Date:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00100-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00100-of-00352.parquet"}]]